QUÉBEC CITY, Aug. 6, 2014 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:
AEZS) (TSX: AEZ) (the "Company") today announced that the Company's
Chairman, CEO, David Dodd, will be presenting a corporate overview at
the Canaccord Genuity 34th Annual Global Growth Conference on
Wednesday, August 13, 2014, at 1pm (Eastern), in the Melbourne Room of
the Intercontinental Hotel in Boston.
A live audio and slide webcast of the presentation will be available via
the Company's website at www.aezsinc.com in the "Newsroom" section, under "Events and Webcasts". A replay of the
webcast will also be available on the Company's website for a period of
About Aeterna Zentaris Inc.
Aeterna Zentaris is a specialty biopharmaceutical company engaged in
developing and commercializing novel treatments in oncology and
endocrinology. The Company's pipeline encompasses compounds at various
stages of development. For more information, visit www.aezsinc.com.
SOURCE: Aeterna Zentaris Inc.
For further information:
Director of Communications
(418) 652-8525 ext. 406